NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Director Louis G Lange sold $829K of NewAmsterdam Pharma Company N.V.
Sold$828,950
$29.41Price
28,186Shares
−34%Stake
What NAMS did after the filing
- The stock from Wed, Mar 11 open, $30.71
- +2.4%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Apr 23 close.
Traded Fri, Mar 6. Filed Tue, Mar 10, 4:58 PM ET, after the close. Returns use the Mar 11 open and the Apr 23 close. Not investment advice.